David McIntyre has two decades of executive experience in the life sciences sector, having held various C-suite level roles at public and private healthcare entities, including HeartWare® International, Inc., AVITA Therapeutics, Inc., Tessa Therapeutics, Inc., and Braeburn, Inc.
David’s experience additionally includes nearly ten years as a Partner at Apple Tree Partners, a multi-billion-dollar life science venture capital and growth equity fund. Prior to entering life sciences, he practiced as a senior attorney at Baker & McKenzie and KPMG, specializing in M&A, initial public offerings, and corporate law, and held various senior finance roles in both multi-national companies and small growth companies.
David has significant experience in the areas of capital raising, M&A, accounting/corporate finance, audit and risk, operations, strategy, and risk management.
David holds a Bachelor of Economics (Accounting) from the University of Sydney, Australia, a Bachelor of Laws from the University of Technology, Sydney and a master’s in business administration from Duke University Fuqua School of Business (Fuqua Scholar) from Durham, North Carolina, USA. David is a Certified Practicing Accountant and is also admitted as a legal practitioner of the Supreme Court of New South Wales and of the High Court of Australia.